PRODUCT INFORMATION

Spaverin tablets are available over the counter at pharmacies.

 
ACTIVE INGREDIENT:
Spaverin 40 mg tablets
Each tablet contains 40 mg of drotaverine hydrochloride.

Spaverin 80 mg tablets
Each tablet contains 80 mg of drotaverine hydrochloride.

DOSAGE:
Usual daily dose:
     Adults: 120-240 mg daily, divided into 2-3 doses
     Children and adolescents: no clinical studies have been conducted with drotaverine in case of children.

Spaverin 80 mg tablets must not be used in children under 12 years of age.

For children aged 6–12 years, the maximum daily dose is 80 mg (two 40 mg tablets), divided into 2 doses.

For children over 12 years of age, the maximum daily dose is 160 mg, divided into 2–4 doses.

Warnings and Precautions for Use
Spaverin must not be taken by patients who are hypersensitive to the active ingredient or any of the other ingredients of the medicinal product, or who have severe liver, kidney or heart disease.
Spaverin 80 mg tablets must not be taken by children under 12 years of age, and Spaverin 40 mg tablets must not be taken by children under 6 years of age.


Particular caution is required when administering drotaverine to patients with low blood pressure (hypotension).
When drotaverine is taken together with levodopa, it may reduce the effectiveness of levodopa in relieving the symptoms of Parkinson’s disease, potentially worsening skeletal muscle rigidity and tremor.


Drotaverine should only be administered to pregnant women after careful consideration.
Due to insufficient clinical data, the use of drotaverine during breastfeeding is not recommended.


Patients should be advised that if they experience dizziness after taking the medicine, they should avoid potentially hazardous activities, including driving and operating machinery.


The following side effects may occur rarely (affecting 1 to 10 in 10,000 patients): headache, dizziness, nausea, palpitations, insomnia, constipation, decreased blood pressure and allergic reactions (oedema, urticaria, skin rash and itching).


Spaverin 40 mg and 80 mg tablets contain lactose monohydrate, which may cause gastrointestinal symptoms in patients with lactose intolerance. The medicine must not be taken by patients with galactose intolerance, lactose intolerance or glucose-galactose malabsorption.


Manufactured by MEDITOP Pharmaceutical Ltd.
  
The complete package leaflet can be downloaded in PDF format from the Downloadable Resources section.

Manufacturer: MEDITOP Pharmaceutical Ltd.


READ THE PATIENT INFORMATION LEAFLET REGARDING RISKS AND SIDE EFFECTS, OR CONSULT YOUR PHYSICIAN OR PHARMACIST!

Spaverin tablets are over-the-counter medicinal products containing drotaverine hydrochloride as the active ingredient.